Goal To carry out state-of-the-art research on the prevention and treatment of HIV infection to promote medical readiness in U.S. military forces.
Objective
  1. Support the development of a safe and effective HIV vaccine.
  2. Support the development of new biochemical and genetic strategies to slow HIV disease progression
  3. Support natural history studies for the purpose of evaluating the efficacy of intervention strategies.
Action Steps
  1. Define the global molecular epidemiology of HIV to assist with candidate vaccine selection.
  2. Explore novel vaccine technologies.
  3. Conduct vaccine trials in endemic areas.
  4. Assess the immune response and efficacy of vaccine candidates.
  5. Evaluate potential therapies for treatment of HIV infection and potential for immune reconstitution.
  6. Evaluate prevalence of drug resistance, develop rapid genetic assay for resistant mutants, and methods for genetic targeting of novel therapies in vivo.
  7. Participate in national surveillance of AZT resistance.
  8. Develop a comprehensive panel of immunologic, virologic, and functional parameters for management of HIV infection.
  9. Support natural history studies and specimen repositories.
Descriptions

Vaccine, therapeutic, and epidemiological research, including vaccine design, development and testing in the U.S. and overseas locations; epidemiologic studies of vaccine field studies; and conclusion of drug treatment and behavior studies.

Resources
FY95
FY96
FY96
$ 38.5 million
$ 27.7 million
$ 24.0 million
Populations
Served

Active duty personnel.

Constituency
Involvement

Clinicians, researchers, and active duty personnel.

 

Back
Top
Continue
[Back]
[Top]
[Continue]

divider
Go to White House Home Page
Go to ONAP Home Page
Go to White House Help Page
White House Home
ONAP Home Page
White House Help